Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 03 Sep 2024

Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment

in Cancer Immunity and Immunotherapy

Yanju Liu
Hongyuan Yang
Tian Li
Na Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460282

5,299 views
9 citations

Original Research

Published on 03 Sep 2024

Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity

in Cancer Immunity and Immunotherapy

Zhigang Li
Ling Hu
Yi Wang
Qi Liu
Jun Liu
Haiyan Long
Qi Li
Liping Luo
Yucai Peng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455019

3,191 views
1 citation

Review

Published on 03 Sep 2024

Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression

in Cancer Immunity and Immunotherapy

Fei Chen
Jian Sheng
Xiaoping Li
Zhaofeng Gao
Lingyu Hu
Minjie Chen
Jianguo Fei
Zhengwei Song

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451474

3,225 views

Editorial

Published on 03 Sep 2024

Editorial: Multidimensionally decoding the impact of tumor heterogeneity on immunotherapy responsiveness in gastrointestinal tumors

in Cancer Immunity and Immunotherapy

Ruizhi Wang
Libo Wang
Yuqing Ren
Xinwei Han
Zaoqu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482206

1,260 views
1 citation

Original Research

Published on 03 Sep 2024

Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study

in Cancer Immunity and Immunotherapy

Zhitao Dong
Chengjun Sui
Jiongjiong Lu
Junwu Guo
Kecai Duan
Kui Wang
Li Geng
Binghua Dai
Jiamei Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463574

2,178 views
1 citation

Review

Published on 03 Sep 2024

Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications

in Cancer Immunity and Immunotherapy

Xun Zheng
Ruonan Sun
Tao Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438235

3,142 views
2 citations

Case Report

Published on 03 Sep 2024

Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms

in Cancer Immunity and Immunotherapy

Liying Yang
Mengdi Wu
Hao Yang
Xiaorong Sun
Lijie Xing
Dan Liu
Ligang Xing
Jinming Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1441404

2,155 views
1 citation

Original Research

Published on 03 Sep 2024

Deciphering colorectal cancer radioresistance and immune microrenvironment: unraveling the role of EIF5A through single-cell RNA sequencing and machine learning

in Cancer Immunity and Immunotherapy

Yaqi Zhong
Xingte Chen
Shiji Wu
Huipeng Fang
Liang Hong
Lingdong Shao
Lei Wang
Junxin Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466226

3,944 views
1 citation

Review

Published on 03 Sep 2024

Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations

in Cancer Immunity and Immunotherapy

Junwei Ge
Xuan Yin
Lujun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457189

3,983 views
1 citation

Review

Published on 02 Sep 2024

Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges

in Cancer Immunity and Immunotherapy

Lin Gan
Wei Wang
Jinxiu Jiang
Ke Tian
Wei Liu
Zhumin Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429836

3,671 views
5 citations

Original Research

Published on 02 Sep 2024

Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment

in Cancer Immunity and Immunotherapy

Yi Liu
Runyu Yang
Mengyao Zhang
Bingyu Yang
Yue Du
Hui Feng
Wenjuan Wang
Busheng Xue
Fan Niu
Pengcheng He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1402951

3,563 views
5 citations

Original Research

Published on 02 Sep 2024

Prognostic cellular senescence-related lncRNAs patterns to predict clinical outcome and immune response in colon cancer

in Cancer Immunity and Immunotherapy

Lichao Cao
Fang Chen
Long Xu
Jian Zeng
Yun Wang
Shenrui Zhang
Ying Ba
Hezi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450135

2,261 views
4 citations

Original Research

Published on 02 Sep 2024

Exploiting branched-chain amino acid metabolism and NOTCH3 expression to predict and target colorectal cancer progression

in Cancer Immunity and Immunotherapy

Kuan Shen
Chuming Zhu
Jianjun Wu
Jiang Yan
Pengyu Li
Shuqing Cao
Xinyi Zhou
Guozhong Yao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430352

1,970 views

Review

Published on 30 Aug 2024

Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy

in Cancer Immunity and Immunotherapy

Minggang Fang
Alexander Allen
Chong Luo
Jonathan D. Finn

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457629

5,620 views
2 citations

Review

Published on 30 Aug 2024

γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations

in Cancer Immunity and Immunotherapy

Jeremy Wee Kiat Ng
Alice Man Sze Cheung

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438962

1,906 views

Review

Published on 30 Aug 2024

Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles

in Cancer Immunity and Immunotherapy

Zhidu Song
Ying Tao
Yue Liu
Jian Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444437

4,058 views
14 citations